{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:48:44Z","timestamp":1790934524983,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.jcin.2009.10.011","type":"journal-article","created":{"date-parts":[[2009,12,23]],"date-time":"2009-12-23T05:42:14Z","timestamp":1261546934000},"page":"1178-1187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent"],"prefix":"10.1016","volume":"2","author":[{"given":"Eric L.","family":"Eisenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Fajadet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rex","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Cowper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Anstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2009.10.011_bib1","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1161\/01.CIR.102.24.2945","article-title":"Percutaneous coronary intervention in the current era compared with 1985\u20131986: the National Heart, Lung, and Blood Institute registries","volume":"102","author":"Williams","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.10.011_bib2","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0735-1097(99)00051-0","article-title":"Acute and long-term cost implications of coronary stenting","volume":"33","author":"Peterson","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.10.011_bib3","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jacc.2008.01.042","article-title":"Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model","volume":"51","author":"Garg","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.10.011_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jacc.2006.02.063","article-title":"Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV trial (comment 268\u20139)","volume":"48","author":"Bakhai","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.10.011_bib5","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/01.CIR.0000136821.99814.43","article-title":"Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial","volume":"110","author":"Cohen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.10.011_bib6","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2009.10.011_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2009.10.011_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11886-008-0043-z","article-title":"Late adverse events after drug-eluting stent implantation","volume":"10","author":"Kong","year":"2008","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jcin.2009.10.011_bib9","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/0003-4819-144-12-200606200-00009","article-title":"Narrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence","volume":"144","author":"Tung","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcin.2009.10.011_bib10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/CIRCULATIONAHA.105.591206","article-title":"Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial","volume":"114","author":"Fajadet","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.10.011_bib11","unstructured":"Medtronic, Inc. FDA executive summary memorandum: Endeavor zotarolimus drug-eluting coronary stent system & Over-the-Wire (OTW), Rapid Exchange (RX), and Multi-Exchange II (MX2) stent delivery systems. P060033. Prepared for the meeting of the Circulatory System Devices Advisory Panel; Gaithersburg, MD; October 10, 2007."},{"key":"10.1016\/j.jcin.2009.10.011_bib12","unstructured":"ENDEAVOR II Investigators. The ENDEAVOR II study: clinical study report (index procedure through 1,080 days). Appendix 2: Endeavor II 36-month report to the FDA. October 29, 2008; Boston, MA. 87\u2013463."},{"key":"10.1016\/j.jcin.2009.10.011_bib13","series-title":"The Trees, Version 25.0: CMS MS-DRG Grouper","year":"2008"},{"key":"10.1016\/j.jcin.2009.10.011_bib14","series-title":"DRG Expert: A Comprehensive Guidebook to the DRG Classification System","year":"2008"},{"key":"10.1016\/j.jcin.2009.10.011_bib15","series-title":"DRG Plus! 2008: A Comprehensive Guide to Medicare Severity Diagnosis Related Groups","year":"2007"},{"key":"10.1016\/j.jcin.2009.10.011_bib16","unstructured":"Mitchel J, Burge R, Lee A, et al. Per case prospective payment for episodes of hospital care. PB95226023. Report presented to: U.S. Department of Commerce National Technical Information Service, 1995. Springfield, VA."},{"key":"10.1016\/j.jcin.2009.10.011_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10916-007-9120-x","article-title":"Outcomes of second revascularization procedures after stent implantation","volume":"32","author":"Konstance","year":"2008","journal-title":"J Med Syst"},{"key":"10.1016\/j.jcin.2009.10.011_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/0272989X9301300210","article-title":"Stability of time-tradeoff utilities in survivors of myocardial infarction","volume":"13","author":"Tsevat","year":"1993","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jcin.2009.10.011_bib19","series-title":"Cost-Effectiveness in Health and Medicine","author":"Gold","year":"1996"},{"key":"10.1016\/j.jcin.2009.10.011_bib20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/biomet\/87.2.329","article-title":"Estimating medical costs with censored data","volume":"87","author":"Bang","year":"2000","journal-title":"Biometrika"},{"key":"10.1016\/j.jcin.2009.10.011_bib21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2307\/2531248","article-title":"Longitudinal data analysis for discrete and continuous outcomes","volume":"42","author":"Zeger","year":"1986","journal-title":"Biometrics"},{"key":"10.1016\/j.jcin.2009.10.011_bib22","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P","article-title":"Analysis of cost data in randomized trials: an application of the non-parametric bootstrap","volume":"19","author":"Barber","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.jcin.2009.10.011_bib23","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1136\/bmj.320.7243.1197","article-title":"How should cost data in pragmatic randomised trials be analysed?","volume":"320","author":"Thompson","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.jcin.2009.10.011_bib24","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1161\/01.CIR.0000127110.49192.72","article-title":"One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial","volume":"109","author":"Stone","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.10.011_bib26","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/01.CIR.0000140721.27004.4B","article-title":"Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials","volume":"110","author":"Cutlip","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.10.011_bib27","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.10.011_bib28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJM199701093360203","article-title":"Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery","volume":"336","author":"Hlatky","year":"1997","journal-title":"N Engl J Med"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879809007262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879809007262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:55:53Z","timestamp":1761846953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879809007262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1936879809007262"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2009.10.011","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2009.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2009.11.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2009.10.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}